Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$6.06M Sell
99,141
-122,825
-55% -$7.45M 0.1% 219
2017
Q2
$13.6M Buy
221,966
+33,745
+18% +$2.05M 0.27% 42
2017
Q1
$11.4M Buy
188,221
+118,110
+168% +$7.17M 0.38% 27
2016
Q4
$3.94M Buy
70,111
+30,706
+78% +$1.8M 0.09% 272
2016
Q3
$2.35M Sell
39,405
-8,384
-18% -$490K 0.05% 572
2016
Q2
$2.63M Sell
47,789
-118,109
-71% -$6.29M 0.05% 553
2016
Q1
$8.38M Buy
165,898
+2,305
+1% +$113K 0.15% 161
2015
Q4
$8.24M Sell
163,593
-54,601
-25% -$2.75M 0.09% 305
2015
Q3
$10.3M Buy
218,194
+116,852
+115% +$6.21M 0.1% 239
2015
Q2
$5.5M Sell
101,342
-8,908
-8% -$500K 0.05% 507
2015
Q1
$6.05M Sell
110,250
-302,767
-73% -$17.1M 0.06% 459
2014
Q4
$22.4M Sell
413,017
-93,377
-18% -$5.2M 0.14% 151
2014
Q3
$28.6M Sell
506,394
-24,732
-5% -$1.39M 0.14% 136
2014
Q2
$29.3M Buy
531,126
+191,993
+57% +$10.5M 0.14% 129
2014
Q1
$18.4M Buy
339,133
+114,337
+51% +$5.92M 0.1% 215
2013
Q4
$10.7M Sell
224,796
-99,246
-31% -$4.54M 0.06% 411
2013
Q3
$14.7M Buy
324,042
+105,639
+48% +$4.82M 0.09% 219
2013
Q2
$9.68M Buy
+218,403
New +$9.75M 0.06% 385

Other funds holding MRK

Spot Trading's MRK Position: Q3 2017 in Review

Spot Trading reduced its Merck (MRK) stake by 83% in Q3 2017, selling an estimated $3.53M and leaving 11,956 shares worth $730K. The position accounts for 0.01% of the portfolio, ranked #1368.

Spot Trading first reported a position in MRK in Q4 2013 and has held it in 11 quarters since. The position peaked at $5.15M in Q1 2014. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Spot Trading held 11,956 shares of Merck worth $730K as of Q3 2017.
  • Spot Trading sold 58,147 Merck shares in Q3 2017, an estimated $3.53M.
  • Merck made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1368 holding.
  • Spot Trading first reported a position in Merck in Q4 2013 and has held it in 11 quarters since.
  • Spot Trading's Merck position peaked at $5.15M in Q1 2014.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.